An evaluation of single dose administration of ALX-0600, a GLP-2 analog, in healthy male subjects.

被引：6
作者：
Metcalfe, AJ
Oliver, SD
Dietrich, J
机构：
[1] NPS Allelix Corp, Mississauga, ON, Canada
[2] Covance Clin Res Unit, Leeds, W Yorkshire, England
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)80083-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4973
引用
收藏
页码：A1072 / A1072
页数：1
相关论文
共 50 条
[31]   Evaluation of the Pharmacokinetics of Abiraterone Acetate and Abiraterone Following Single-Dose Administration of Abiraterone Acetate to Healthy Subjects [J].
Bouhajib, Mohammed ;
Tayab, Zia .
CLINICAL DRUG INVESTIGATION, 2019, 39 (03) :309-317
[32]   SINGLE- AND MULTIPLE-DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF ERTUGLIFLOZIN, AN ORAL SELECTIVE INHIBITOR OF SGLT2, IN HEALTHY SUBJECTS. [J].
Nucci, G. ;
Le, V. ;
Sweeney, K. ;
Amin, N. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 :S83-S83
[33]   KINETICS OF ACETAMINOPHEN AFTER SINGLE-DOSE AND MULTIPLE-DOSE ORAL-ADMINISTRATION AS A GRADIENT MATRIX SYSTEM TO HEALTHY MALE-SUBJECTS [J].
VANBOMMEL, EMG ;
RAGHOEBAR, M ;
TUKKER, JJ .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1991, 12 (05) :355-366
[34]   Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Domperidone After Single-Dose Administration in Healthy Chinese Subjects [J].
Ye, Libing ;
Shen, Minmin ;
Chen, Yingrong ;
Li, Xiaofeng ;
Xu, Min ;
Yao, Chong ;
Yang, Shuixin .
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09) :1084-1091
[35]   Effect of a single cyclosporine A (NEORAL™) dose on the single-dose pharmacokinetics (PK) of sitagliptin (MK-0431), a dipeptidyl peptidase-IV inhibitor (DPP-IV), in healthy male subjects. [J].
Krishna, R ;
Bergman, AJ ;
Larson, P ;
Cote, J ;
Lasseter, KC ;
Pierre, M ;
Wang, AQ ;
Zeng, W ;
Chen, L ;
Wagner, JA ;
Herman, GA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) :P63-P63
[36]   Single dose escalation study investigating the pharmacodynamics, safety, and pharmacokinetics of BAY 59-7939 an oral, direct factor Xa inhibitor in healthy male subjects. [J].
Kubitza, D ;
Becka, M ;
Wensing, G ;
Voith, B ;
Zuehlsdorf, M .
BLOOD, 2003, 102 (11) :813A-813A
[37]   Effect of CYP2D6 genetic polymorphism on the pharmacokinetics and ECG pharmacodynamics after single oral administration of flecainide in healthy subjects. [J].
Lim, K. S. ;
Kim, J. ;
Kim, J. ;
Kim, B. ;
Kim, M. ;
Kim, T. ;
Chung, Y. ;
Jeon, J. ;
Tae, Y. ;
Yi, S. ;
Eum, S. ;
Cho, J. ;
Yu, K. ;
Shin, S. ;
Jang, I. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 :S81-S81
[38]   Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects [J].
Sidharta, Patricia N. ;
Diamant, Zuzana ;
Dingemanse, Jasper .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 (06) :690-699
[39]   Dose-response effect of a single administration of oral hexyl-insulin to monoconjugate 2 in healthy nondiabetic subjects [J].
Wajcberg, E ;
Miyazaki, Y ;
Triplitt, C ;
Cersosimo, E ;
DeFronzo, RA .
DIABETES CARE, 2004, 27 (12) :2868-2873
[40]   Safety, tolerability and pharmacokinetics of R1626, a novel nucleoside analog targeting hcv polymerase: Results from a phase I single dose escalation trial in healthy subjects. [J].
Robson, R. ;
Berns, H. ;
Brand, M. ;
Feltner, S. ;
Hill, G. ;
Ipe, D. ;
Love, J. ;
Mannino, M. ;
O'Mara, E. ;
Tu, Y. ;
Washington, C. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 :S98-S98
12345